Hyperthyroidism With Heart Disease or in Pregnancy: How Treatment Is Adapted

Two patients can sit in the same waiting room with the same blood result and leave with completely different plans. One is fourteen weeks pregnant and has been told her racing pulse is not just nerves. The other is seventy-one, already takes medicine for an irregular heartbeat, and cannot understand why he is losing weight while eating more than ever. Both have an overactive thyroid. Neither will be treated the way a textbook describes a healthy thirty-year-old.

That is the honest core of hyperthyroidism treatment in pregnancy and heart disease: the diagnosis is the same, but the margins for error shrink. A medicine that is routine in one person becomes a careful trade-off in another, and a treatment that is standard for most adults is simply off the table for someone carrying a baby.

This explainer walks through why those adaptations happen, what the evidence supports, and which questions are worth bringing to the team making the decisions.

Why hyperthyroidism treatment in pregnancy and heart disease follows different rules

Hyperthyroidism means the thyroid gland is releasing more hormone than the body needs. Those hormones set the pace for nearly every organ, so an excess speeds up the heart, raises body temperature, burns through calories and makes muscles tremble. In a healthy adult the body tolerates this for a while. In pregnancy, and in a heart that is already strained, the tolerance is far thinner.

Pregnancy adds a second patient. Thyroid hormone, antithyroid medicines and certain antibodies all cross the placenta, so every decision about the mother’s gland has a potential effect on the developing baby’s thyroid, growth and heart rate. Radioactive iodine, a mainstay for adults, is ruled out entirely because it would be taken up by the fetal thyroid as well as the mother’s, according to the NIH’s NIDDK guidance on thyroid disease in pregnancy.

Heart disease changes the arithmetic in another way. Excess thyroid hormone forces the heart to beat faster and harder, which a healthy heart absorbs but a heart with narrowed arteries, a weak pump or a pre-existing rhythm problem may not. The NHS lists atrial fibrillation and heart failure among the recognized complications of an untreated overactive thyroid, and both are more likely, and more dangerous, when the heart was already compromised.

So the adaptations are not about a different disease. They are about the same disease landing in a body with less reserve, or in two bodies at once. Everything that follows flows from that single idea: control the hormone excess, but choose the route that costs the least for this particular person.

How hyperthyroidism treatment actually works, in plain language

There are four tools, and each works on a different link in the chain.

Antithyroid medicines, known as thionamides, block the enzyme the thyroid uses to attach iodine to hormone building blocks. They do not destroy the gland; they slow the factory. Because hormone already circulating must be used up first, symptoms ease gradually. The NHS notes it usually takes one to two months for these medicines to bring symptoms under control, and a typical course lasts around twelve to eighteen months before the team considers stopping to see whether the condition has settled.

Beta-blockers are a class of heart medicines that blunt the effect of adrenaline on the heart and nerves. They do not change thyroid hormone levels at all, but they calm the palpitations, tremor and anxiety while the thionamides take hold. Mayo Clinic describes them as a bridge, not a treatment of the gland itself.

Radioactive iodine is swallowed as a capsule or liquid. The thyroid absorbs iodine avidly, so the radiation concentrates in the gland and shrinks overactive tissue over weeks to months, per Mayo Clinic. Many people eventually become underactive and need thyroid hormone replacement afterwards.

Surgery, called thyroidectomy, removes part or all of the gland. It is the fastest route to permanent control and the only option that works regardless of what antibodies are doing, but it involves anesthesia, a neck incision and small risks to the voice nerves and the calcium-regulating parathyroid glands.

In an otherwise healthy adult, the team can mix these freely. Pregnancy and heart disease each remove or reorder options, which is where the rest of this article goes.

How does hyperthyroidism affect the baby during pregnancy?

The baby is affected through three channels: the mother’s overall health, the hormones and antibodies that cross the placenta, and the medicines used to treat her.

Uncontrolled maternal hyperthyroidism is linked by the NIDDK to miscarriage, premature birth, low birth weight and preeclampsia, a pregnancy condition of high blood pressure and organ strain. It also raises the mother’s risk of heart failure and of thyroid storm, a rare, life-threatening surge of thyroid hormone. These are the reasons clinicians do not simply wait and watch a clearly overactive gland in pregnancy.

The second channel is specific to Graves’ disease, the autoimmune cause behind most pregnancy hyperthyroidism. Graves’ disease produces antibodies that switch the thyroid on. Those antibodies can cross the placenta and, in a minority of babies, overstimulate the fetal thyroid, causing a fast fetal heart rate, poor growth or an enlarged thyroid that can be seen on ultrasound. The NIDDK explains that this is why antibody levels are often checked during pregnancy and why the newborn may be tested after birth.

The third channel is the medicine. Antithyroid drugs cross the placenta and can lower the baby’s thyroid output if the mother’s levels are pushed too low. The guiding principle, reflected in NHS and NIDDK guidance, is to use the lowest amount that keeps the mother’s free hormone at the upper end of the normal range, rather than aiming for a perfect midpoint. That deliberate under-treatment protects the baby’s gland.

None of this means a baby exposed to maternal hyperthyroidism is destined for trouble. It means pregnancy is monitored more closely, usually with shared care between obstetric and endocrine teams.

Graves disease and pregnancy: can you have a healthy pregnancy?

Many people with Graves’ disease do carry pregnancies to term and deliver healthy babies, and the NIDDK is explicit that well-managed thyroid disease is compatible with a healthy pregnancy. What the evidence does not support is the idea that the diagnosis alone decides the outcome. Control does.

Timing matters more than most people expect. Graves’ disease often behaves differently across the three trimesters. Early pregnancy can temporarily worsen hyperthyroidism, partly because the pregnancy hormone hCG, which rises steeply in the first trimester, weakly stimulates the thyroid in the same way the Graves’ antibodies do. The immune system then tends to quieten in the second and third trimesters, so medicine needs frequently fall and some people are able to stop under supervision. After birth, the immune system rebounds and relapse is common, which is why postpartum follow-up is built into the plan rather than offered as an afterthought.

Pre-conception planning changes the whole picture. Someone whose Graves’ disease is already stable on treatment, or who has had definitive treatment and is now on stable thyroid replacement, starts pregnancy with far less risk than someone diagnosed at ten weeks with a resting pulse over a hundred. The NHS advises people with an overactive thyroid who are planning a pregnancy to tell their doctor beforehand, precisely so medicine choices can be reviewed in advance.

One caution worth stating plainly: a prior definitive treatment does not remove the antibodies. Someone who had radioactive iodine or surgery years ago can still have circulating Graves’ antibodies that cross the placenta, so antibody testing in pregnancy may still be recommended even when the mother’s own thyroid is no longer overactive.

Antithyroid medication in pregnancy: why the choice changes by trimester

Two thionamides are in common use: propylthiouracil and methimazole (known as carbimazole in some countries, which the body converts into methimazole). Outside pregnancy, methimazole is generally preferred because it is taken less often and carries a lower risk of serious liver injury. Pregnancy flips that preference, but only for part of the time.

In the first trimester, when the baby’s organs are forming, methimazole has been associated with a small but recognized pattern of birth defects involving the skin of the scalp, the gut and the face. The NIDDK therefore describes propylthiouracil as the usual choice in early pregnancy. Propylthiouracil, however, carries a rare risk of severe liver damage for the mother, so after the first trimester many clinicians switch back to methimazole for the remainder of the pregnancy. The exact switching point, and whether to switch at all, is a judgment the prescribing clinician makes with the patient, taking into account how stable her levels are and how she has tolerated each drug.

Both medicines cross the placenta, and both can suppress the fetal thyroid if the mother is over-treated. That is why pregnancy monitoring is more frequent than usual, typically with thyroid blood tests every few weeks and adjustments aimed at the gentlest effective amount. This article does not describe amounts or schedules; those belong to the prescriber.

Rare but serious side effects apply in pregnancy as they do outside it. The NHS flags a sudden sore throat, mouth ulcers or fever as possible signs of agranulocytosis, a steep fall in infection-fighting white cells, and advises urgent testing. Yellowing of the skin or eyes, dark urine or severe abdominal pain can signal liver injury. Anyone taking these medicines should know these signs before the first prescription is filled.

Which treatment is used for severe, hard-to-control hyperthyroidism in pregnancy?

This is one of the most searched questions on the topic, and the honest answer is that the options narrow to two: continuing to adjust antithyroid medicine, or surgery, usually timed for the second trimester.

Radioactive iodine is never used in pregnancy. The NIDDK states this without qualification, because the radiation would be taken up by the fetal thyroid and could permanently destroy it. It is also avoided during breastfeeding and, per the NHS, pregnancy should be avoided for six months after a dose. Pregnancy testing before radioiodine is routine for anyone who could conceive.

Surgery becomes the consideration when antithyroid medicines cannot control hormone levels, when the person cannot tolerate them because of a serious reaction such as agranulocytosis or liver injury, or when a very large goiter is compressing the airway. The second trimester is generally regarded as the safest window: organ formation is complete, the uterus is not yet large enough to complicate anesthesia and positioning, and the risk of triggering preterm labor is thought to be lower than in the third trimester. Even so, thyroid surgery in pregnancy is uncommon and is coordinated between obstetric, surgical, anesthetic and endocrine teams.

Beta-blockers are frequently used alongside either path to control heart rate and tremor. In pregnancy they are typically used for short periods, because longer use has been associated with slower fetal growth and low blood sugar in the newborn. Whether and how long to use one is a prescriber’s decision weighed against how fast the mother’s heart is running.

What “severe” means also deserves precision. A high hormone level on paper is not the same as a mother with a resting pulse over 120, weight loss and heart strain. The team treats the person, not the number, and will often intensify monitoring before escalating treatment.

Hyperthyroidism and atrial fibrillation: what the heart is doing

Thyroid hormone acts directly on heart muscle and on the heart’s electrical system. In excess, it shortens the time cells take to recover between beats, raises the resting heart rate, increases the force of each contraction and widens blood vessels. The net effect is a heart working like someone jogging while they sit still.

In the upper chambers, that extra excitability sets the stage for atrial fibrillation, an irregular and often rapid rhythm in which the atria quiver rather than contract cleanly. The NHS names atrial fibrillation as a recognized complication of an untreated overactive thyroid, and the risk climbs with age and with any pre-existing heart disease. An overactive thyroid is one of the first things a cardiologist checks for when atrial fibrillation appears without an obvious cause.

Atrial fibrillation matters beyond the unpleasant sensation of a fluttering chest. Blood that is not pumped cleanly out of the atria can pool and clot, and a clot that travels to the brain causes a stroke. The American Heart Association states that atrial fibrillation increases a person’s stroke risk roughly fivefold. That is why, when thyroid-driven atrial fibrillation is found, the conversation often includes whether an anticoagulant, a medicine that reduces clotting, is appropriate while the rhythm is unstable.

The encouraging part of the evidence is that thyroid-driven atrial fibrillation frequently resolves on its own once hormone levels return to normal, particularly in younger people without structural heart disease. In older people or those with a damaged heart, it may persist and need its own treatment even after the thyroid is controlled. That uncertainty is exactly why rhythm follow-up continues after the thyroid numbers look fine.

Hyperthyroidism heart failure risk: adapting treatment when the heart is already strained

Heart failure means the heart cannot pump well enough to meet the body’s demands. Hyperthyroidism raises those demands at the exact moment it pushes the heart harder, so a heart that was quietly coping can tip over. The NHS lists heart failure among the complications of untreated hyperthyroidism, and the risk is concentrated in people with existing coronary artery disease, valve disease or a weakened heart muscle.

When heart disease is already present, several things usually change in the plan. First, beta-blockers tend to move from optional to early, because controlling heart rate protects the heart while thionamides are still taking effect. The specific choice depends on the heart condition; some beta-blockers are avoided in certain lung or circulation problems, which is a prescriber’s call. Second, there is less willingness to tolerate a prolonged period of high hormone levels. Where a healthy adult might reasonably try eighteen months of medicine and see what happens, someone with heart disease may be steered toward definitive treatment sooner. Third, endocrine and cardiac teams usually share the case rather than treating in sequence.

Radioactive iodine brings its own wrinkle for cardiac patients. In the first weeks after a dose, hormone levels can rise transiently as damaged thyroid cells release stored hormone. In a person with a fragile heart, that spike is unwelcome, so clinicians often pre-treat with antithyroid medicine to empty the gland’s stores and continue beta-blockers across the window.

One more adaptation is specific to cardiology itself. Amiodarone, an antiarrhythmic rich in iodine, is a known cause of hyperthyroidism, and amiodarone-induced thyrotoxicosis is notoriously difficult to manage. Anyone who develops an overactive thyroid while taking it should expect the two specialties to coordinate closely, and should never stop the heart medicine on their own.

Who is usually treated straight away, and who is usually asked to wait

Prompt treatment is the norm for anyone with overt hyperthyroidism, meaning high free thyroid hormone with a suppressed thyroid-stimulating hormone (TSH, the pituitary signal that normally drives the gland) plus symptoms. Within that group, pregnant patients and people with heart disease are moved to the front of the queue because the cost of delay is higher for them.

Waiting, or watchful monitoring, is more common in three situations.

• Subclinical hyperthyroidism, where TSH is low but free hormone levels are still normal. Mayo Clinic notes that treatment here is individualized, weighted toward older adults and those with heart disease or bone loss, and that others may simply be rechecked.
• Transient gestational thyrotoxicosis, the first-trimester hormone rise driven by hCG rather than by autoimmunity, often accompanied by severe nausea. The NIDDK explains this usually settles as hCG falls and generally does not require antithyroid medicine.
• Thyroiditis, a temporary inflammation that leaks stored hormone and then burns out. Blocking production does not help because the gland is not overproducing; symptom relief with beta-blockers and time is the usual approach.

People are also asked to wait before certain treatments rather than before treatment altogether. Radioactive iodine requires a negative pregnancy test and, per the NHS, avoiding pregnancy for six months afterwards (four months for men fathering a child). Elective thyroid surgery is generally postponed until hormone levels are controlled, because operating on an overactive gland raises the risk of thyroid storm. In cardiac patients, elective procedures of any kind are often deferred until the thyroid is settled.

Deciding which group someone falls into is clinical judgment informed by blood tests, antibody results, ultrasound and the whole picture of their health. It is not something a lab result alone can settle.

Hyperthyroidism treatment in pregnancy and heart disease: the options side by side

The table below summarizes how each tool is typically positioned. It reflects mainstream guidance from the NHS, Mayo Clinic and the NIDDK and is a map, not a prescription; the treating team decides which route applies.

Option	Standard adult	In pregnancy	With heart disease
Antithyroid medicine (thionamides)	Usual first choice; roughly 12–18 month course (NHS)	Mainstay; drug often changes by trimester; smallest effective amount to protect the fetal thyroid	First choice but with lower tolerance for prolonged high levels; often paired with early beta-blockers
Beta-blockers	Short-term symptom relief	Short courses only; longer use linked to slower fetal growth	Often started early and continued longer; choice tailored to the heart condition
Radioactive iodine	Common definitive option; works over weeks to months (Mayo Clinic)	Never used; avoid pregnancy for 6 months after a dose (NHS)	Used, often after pre-treatment to avoid a hormone surge
Surgery (thyroidectomy)	For large goiters, intolerance of medicine or patient preference	Reserved for uncontrolled disease or serious drug reactions; second trimester preferred	Considered when rapid, permanent control is needed; timed after hormone levels are stabilized
Monitoring frequency	Every few weeks initially, then spaced out	More frequent blood tests through pregnancy; antibody testing; fetal checks	Thyroid tests plus rhythm and heart function follow-up

Two patterns stand out. Pregnancy removes an option and adds caution to the rest, while heart disease keeps every option but compresses the timeline and adds a second specialist. In both cases the underlying goal, bringing hormone levels into a safe range without overshooting, is identical.

What the following weeks and months usually look like

Timelines here are typical ranges drawn from published guidance, not guarantees for any individual.

In the first days after starting antithyroid medicine, most people notice nothing from the drug itself. If a beta-blocker has been added, the racing pulse and tremor often settle quickly, which can create the impression that the thyroid is fixed. It is not; hormone levels usually take weeks to fall. The NHS describes one to two months before thionamides bring symptoms under control, and blood tests during this phase are typically repeated every few weeks so the amount can be adjusted.

In pregnancy, the rhythm of testing is tighter, usually monthly or more often if levels are unstable, with the aim of keeping free hormone at the upper end of normal. Many people find their needs fall as the second trimester progresses, and the team may reduce or, in some cases, stop medicine under close watch. Fetal growth and heart rate are checked at routine scans; if antibody levels are high, additional fetal assessment may be arranged.

In heart disease, the early weeks include rhythm and blood pressure checks alongside thyroid tests. If atrial fibrillation was present, the team watches whether it resolves as hormone levels normalize, which commonly happens within months, or whether it persists and needs its own strategy.

After radioactive iodine, Mayo Clinic notes symptoms typically subside over several weeks to months. Many people later become underactive and begin thyroid hormone replacement, which is monitored for life. After surgery, replacement starts almost immediately if the whole gland is removed, with calcium levels checked in the first days.

The longest horizon belongs to anyone on a medicine course: the NHS describes roughly twelve to eighteen months, followed by a trial off treatment and continued periodic testing because relapse is possible.

After the birth: breastfeeding, postpartum flares and newborn checks

Delivery is not the end of the thyroid story; in Graves’ disease it is often the start of a new chapter. The immune quieting of late pregnancy reverses after birth, and the NIDDK notes that Graves’ disease frequently worsens in the months after delivery. Someone who stopped medicine in the third trimester may need it again, so a postpartum thyroid test is usually scheduled rather than left to chance.

A separate condition can muddy the picture. Postpartum thyroiditis is an inflammation of the gland that appears in the first year after birth, often with a short overactive phase followed by an underactive one. It is not Graves’ disease and is treated differently, usually with symptom relief rather than antithyroid medicine. Distinguishing the two sometimes requires antibody tests or a specialized scan, which is one reason new parents with palpitations, weight change or unusual fatigue should mention a thyroid history rather than attribute everything to sleep loss.

Breastfeeding is generally considered compatible with antithyroid medicine under clinician supervision, according to the NIDDK, because only small amounts pass into milk. Radioactive iodine, by contrast, is not given to anyone who is breastfeeding, and breastfeeding is stopped before a dose rather than paused.

The newborn is checked too. Babies born to mothers with Graves’ antibodies can develop temporary hyperthyroidism in the first days to weeks as the antibodies that crossed the placenta linger. Conversely, a baby exposed to antithyroid medicine may have a briefly sluggish thyroid. Standard newborn screening picks up most issues, and the pediatric team may add extra blood tests when the maternal history warrants it. These effects are temporary in the large majority of cases because the maternal antibodies clear from the baby’s blood over weeks.

What people often get wrong about hyperthyroidism in pregnancy and heart disease

“If my pulse is normal on a beta-blocker, my thyroid is under control.” Beta-blockers hide the symptoms without lowering the hormone. Only blood tests show whether the gland is settling, which is why they continue even when you feel well.

“Antithyroid medicine is dangerous in pregnancy, so it is safer to stop.” The evidence runs the other way. Untreated hyperthyroidism is linked by the NIDDK to miscarriage, prematurity, preeclampsia and maternal heart failure. The medicines carry real but smaller risks, managed by careful choice and the lowest effective amount. Stopping without advice swaps a controlled risk for an uncontrolled one.

“Graves’ disease means I cannot have children.” Fertility can be reduced while hormone levels are high, but it generally recovers with treatment, and many people with Graves’ disease have healthy pregnancies when the condition is stabilized beforehand.

“Once I have had radioactive iodine, pregnancy is no longer a thyroid issue.” The antibodies can persist for years after the gland is treated and can still affect the baby, so antibody testing in a later pregnancy may be advised. Replacement hormone needs also typically rise in pregnancy and require monitoring.

“My atrial fibrillation will disappear as soon as the thyroid is treated.” Often it does, particularly in younger people without structural heart disease. In older adults or damaged hearts it may persist, and the stroke risk the American Heart Association describes does not pause while waiting to find out.

“Thyroid storm only happens if you ignore symptoms for years.” It can be triggered by infection, surgery, labor or abruptly stopping medicine in someone whose levels are still high. It is rare, but the trigger is often a single event, not a long neglect.

Questions to ask your care team

Appointments move fast. Bringing a short list keeps the conversation anchored on what matters for your situation rather than the general case.

• What is causing my hyperthyroidism, and does that change which treatments are appropriate for me?
• How often will my thyroid levels be checked over the next three months, and what range are you aiming for?
• If I am pregnant or planning to be, which antithyroid medicine will I take in each trimester, and why?
• Will my Graves’ antibodies be measured, and what would a high result mean for the baby’s monitoring?
• Which side effects should prompt me to stop and call the same day, and which can wait for the next visit?
• If I have heart disease, who is coordinating between my cardiologist and my endocrinologist, and do they have each other’s notes?
• Do I need a rhythm monitor, an echocardiogram or a blood thinner while my levels are high?
• If medicine does not control my levels, what is the next step, and when would you consider it?
• After radioactive iodine or surgery, what follow-up will I need, and for how long?
• What is the plan for the months after delivery, and who will arrange the postpartum thyroid test?
• Is breastfeeding compatible with the treatment you are recommending?
• Are any of my other medicines, such as an antiarrhythmic, contributing to the thyroid problem?

Write the answers down, or ask for them in writing. Shared decisions work best when both sides can see the same plan.

When to call your doctor

Most hyperthyroidism follow-up happens on a schedule, but some situations should not wait for the next appointment.

Seek emergency care immediately if you develop a very fast or irregular heartbeat with chest pain, breathlessness at rest, confusion or agitation, a high fever, or vomiting and diarrhea that come on suddenly. Johns Hopkins describes this combination as the picture of thyroid storm, a rare, life-threatening surge of thyroid hormone that needs hospital treatment. In pregnancy, add severe headache, visual disturbance, sudden swelling of the face or hands, or reduced fetal movement to the emergency list, as these can signal preeclampsia or fetal distress.

Call your doctor the same day, and arrange an urgent blood test, if you are taking an antithyroid medicine and develop a sore throat, mouth ulcers, fever or any infection that feels unusually severe. The NHS flags these as possible signs of agranulocytosis, a dangerous drop in white blood cells. Do the same for yellowing of the skin or eyes, dark urine, pale stools or pain in the upper right abdomen, which can indicate liver injury.

Contact your team within a few days for new or worsening palpitations, unexplained weight loss, persistent tremor, heat intolerance, new swelling in the neck, or eye symptoms such as grittiness, bulging or double vision. If you have heart disease and notice new ankle swelling, breathlessness lying flat, or needing extra pillows to sleep, report it promptly; these can be early signs of heart strain.

If you are pregnant, breastfeeding or planning a pregnancy and have not yet told the clinician managing your thyroid, make that call now. Every treatment decision in this article depends on them knowing.

Frequently asked questions

How does hyperthyroidism affect the baby during pregnancy?

Untreated maternal hyperthyroidism is linked by the NIDDK to miscarriage, preterm birth, low birth weight and preeclampsia. In Graves’ disease, antibodies crossing the placenta can overstimulate the fetal thyroid, causing a fast heart rate or poor growth in a minority of babies. Antithyroid medicine can also slightly suppress the baby’s thyroid if the mother is over-treated, which is why levels are kept at the upper end of normal.

Which treatment is used for severe, unmanageable hyperthyroidism in a patient who is pregnant?

When antithyroid medicine cannot control levels or causes a serious reaction, surgery to remove the thyroid is the usual alternative, generally timed for the second trimester. Radioactive iodine is never used in pregnancy. Short courses of beta-blockers may support heart rate control alongside either route. The decision is made jointly by obstetric, endocrine, surgical and anesthetic teams based on the individual case.

Is it possible to have a successful pregnancy with Graves' disease?

Yes, many people with Graves’ disease carry healthy pregnancies, and the NIDDK describes well-managed thyroid disease as compatible with a healthy pregnancy. Outcomes track with control rather than diagnosis, so stabilizing hormone levels before conception, keeping to the monitoring schedule, and planning for the postpartum period, when Graves’ disease often flares, are the factors that matter most.

What are the risks of birth defects for a baby with Hashimoto's disease?

Hashimoto’s disease causes an underactive, not overactive, thyroid, and the condition itself is not known to cause structural birth defects. The concern with untreated or under-treated hypothyroidism in pregnancy is different: the NIDDK links it to miscarriage, preeclampsia, low birth weight and effects on the baby’s brain development. Thyroid hormone replacement is considered safe in pregnancy and needs usually rise, so levels are monitored closely.

Can antithyroid medication in pregnancy harm the baby?

Both common antithyroid medicines cross the placenta. Methimazole in the first trimester has been associated with a rare pattern of birth defects, which is why propylthiouracil is usually preferred early, according to the NIDDK. Either drug can lower the baby’s thyroid output if the mother is over-treated. Clinicians manage this by using the smallest effective amount and testing frequently; the overall risk of untreated hyperthyroidism is considered greater.

Does hyperthyroidism cause atrial fibrillation, and does it go away?

Excess thyroid hormone makes the heart’s upper chambers electrically irritable, and the NHS lists atrial fibrillation as a recognized complication of untreated hyperthyroidism. In younger people without structural heart disease it frequently resolves within months of hormone levels normalizing. In older adults or those with existing heart disease it may persist and need its own treatment, so rhythm follow-up continues after the thyroid is controlled.

What is the hyperthyroidism heart failure risk if I already have heart disease?

Hyperthyroidism raises heart rate and the heart’s workload at the same time, so a heart with narrowed arteries, valve disease or weak muscle can decompensate. The NHS names heart failure among complications of untreated hyperthyroidism, and the risk is concentrated in people with pre-existing heart conditions. Treatment is therefore adapted with earlier beta-blockers, faster escalation to definitive options and shared care between cardiology and endocrinology.

Can I breastfeed while taking antithyroid medicine?

The NIDDK indicates antithyroid medicines are generally considered compatible with breastfeeding under clinician supervision, because only small amounts pass into milk. The prescriber will choose the medicine and monitoring plan, and the baby’s pediatrician may check its thyroid function. Radioactive iodine is different: it is not given to anyone who is breastfeeding, and breastfeeding is stopped before a dose rather than temporarily paused.

How long after radioactive iodine should I wait before trying to conceive?

The NHS advises avoiding pregnancy for six months after radioactive iodine treatment, and advises men to avoid fathering a child for four months. This allows the radiation to clear and thyroid levels to stabilize, since many people become underactive afterwards and need replacement hormone adjusted. Your treating team may suggest a longer interval if your levels are not yet settled.

Can hyperthyroidism in pregnancy be mistaken for normal pregnancy symptoms?

Yes. A faster pulse, feeling warm, nausea and fatigue are common in early pregnancy, and a mild, temporary hormone rise driven by the pregnancy hormone hCG can occur in the first trimester, especially with severe vomiting. The NIDDK notes this usually settles without antithyroid medicine. Blood tests and, where needed, antibody tests distinguish it from Graves’ disease, which does require treatment.

References

• NIDDK (NIH): Thyroid Disease & Pregnancy
• NHS: Overactive thyroid (hyperthyroidism), Treatment
• NHS: Overactive thyroid (hyperthyroidism), Complications

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.